![]() |
市場調查報告書
商品編碼
2026864
2034年醫用高光譜影像市場預測-按產品、技術、應用、最終用戶和地區分類的全球分析Medical Hyperspectral Imaging Market Forecasts to 2034 - Global Analysis By Product, Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球醫療高光譜影像市場規模將達到 27 億美元,並在預測期內以 15.1% 的複合年成長率成長,到 2034 年將達到 84 億美元。
高光譜影像(HSI)是醫學領域一項新興的影像技術,特別適用於影像導引手術和疾病辨識。 HSI透過獲取具有2D空間維度和一維頻譜維度的超立方體資料集來實現這一目標。憑藉空間解析度和頻譜成像能力,HSI能夠提供關於組織生理功能、形態和成分的診斷資訊。
根據國際癌症研究機構(IARC)的數據,2020年全球報告了超過190萬例新增大腸直腸癌病例,導致93萬人死亡。預計到2040年,這些數字將分別以以年度為基礎63%(新增病例320萬例)和73%(死亡人數160萬)的速度成長。
癌症發生率上升
醫學高光譜影像的主要應用之一是固態腫瘤的檢測。高光譜成像的主要優勢包括:癌症診斷的非侵入性、無需組織切片檢查以及無需即時造影劑即可提供診斷特徵。此外,隨著癌症發生率的上升,對醫學高光譜影像的需求不斷成長,市場也不斷擴大。
醫用高光譜影像系統成本過高
高光譜影像系統的成本包括高光譜遙測相機、光源、軟體、反射板、顯微鏡以及其他配件。然而,高光譜遙測相機和顯微鏡的成本會對醫療系統在預算範圍內提供治療帶來壓力。例如,中國光電科技公司生產的高光譜遙測相機售價在45,000美元至48,800美元之間。在美國,實施這項技術的成本通常從50,000美元起,而且往往更高。
加大對醫療應用領域的研究力道。
由於高光譜遙測系統在醫學領域的應用仍處於探索階段,許多研究致力於將其應用於疾病診斷。根據美國國家生物技術資訊中心(NCBI)2023年1月發布的研究報告,高光譜影像可能有助於預測糖尿病足潰瘍(DFU)的癒合速度。該研究表明,高光譜影像是一種經濟有效的檢測方法,易於融入常規臨床實踐,並可能為糖尿病足潰瘍的癒合能力提供重要資訊。
大規模資料存儲
資料的複雜性需要大規模的儲存空間,這限制了市場成長並增加了企業的成本。例如,根據 Hindawi 於 2022 年 4 月發表的一篇論文,高光譜影像系統結合機器學習和深度學習,由於需要儲存大量數據,面臨空間複雜性的挑戰。然而,測試和訓練所需的原始高光譜成像資料量龐大,耗時較長,這將限制整個預測期內的市場成長。
自2019年12月疫情爆發並蔓延至全球213個國家地區後,世界衛生組織(世衛組織)於2020年3月宣布新冠肺炎疫情構成國際關注的突發公共衛生事件。新冠肺炎疫情導致美國、中國、日本、印度和德國等主要國家長期實施封鎖措施,非必要製造業設施被迫關閉。這導致全球大量工業設施停產或停工。
在預測期內,相機行業預計將佔據最大的市場佔有率。
由於成像設備對於改進治療方法和提高診斷準確性至關重要,因此相機領域佔據了最大的市場佔有率。高高光譜遙測相機能夠記錄的寬波長範圍使其能夠對生物組織進行極其精細的分析,從而提高疾病檢測的準確性。此外,高光譜影像在即時組織識別、疾病檢測和手術導航等領域的廣泛應用也推動了市場需求的成長。這些相機能夠為醫療專業人員提供獨特的組織成分訊息,從而支持早期檢測和治療方案的發展。
在預測期內,眼科產業預計將呈現最高的複合年成長率。
由於醫學高光譜影像具有獨特的優勢,有望徹底改變眼科診斷方式,眼科領域預計將迎來盈利發展。醫學高光譜影像能夠提供視網膜組織的全面訊息,從而實現對多種眼科疾病(包括老齡化黃斑部病變和糖尿病視網膜病變)的精準診斷。此外,該技術能夠從眼組織中提取頻譜訊息,有助於早期發現異常情況,並為個人化治療方法提供寶貴資訊。
由於醫學的進步和技術應用的擴展,亞太地區已佔據最大的市場佔有率。該地區人口成長和醫療基礎設施投資的增加推動了對最新醫學影像技術的需求。高高光譜影像提供的廣泛頻譜資訊提高了疾病診斷的準確性和手術的精準度,這與該地區日益重視尖端醫療技術的趨勢相契合。此外,癌症和心血管疾病等慢性病的日益普遍也推動了對尖端診斷工具的需求,而高光譜影像正被視為一種突破性的治療方法。
亞太地區正蓄勢待發,可望迎來蓬勃發展,這主要得益於中國、印度和日本等國政府對醫療基礎建設和科研能力的大力支持。該地區充滿活力的科學研究群體以及學術機構與產業界的密切合作,持續推動技術創新。此外,醫療專業人員對高光譜影像技術在眼科、皮膚科和腫瘤科等眾多醫學領域益處的認知不斷加深,也進一步促進了該技術的應用。
According to Stratistics MRC, the Global Medical Hyperspectral Imaging Market is accounted for $2.7 billion in 2026 and is expected to reach $8.4 billion by 2034 growing at a CAGR of 15.1% during the forecast period. Hyperspectral imaging (HSI), a newly developed imaging method used in medicine, is especially useful for image-guided surgery and the identification of illnesses. The hypercube dataset, which has two spatial dimensions and one spectral dimension, is acquired through HSI. Through spatially resolved spectrum imaging, HSI provides diagnostic information on tissue physiology, shape, and composition.
According to the International Agency for Research on Cancer (IARC), in 2020, more than 1.9 million new cases of colorectal were reported leading to 930,000 deaths. The mentioned statistics are predicted to increase by 63% (3.2 million new cases) and 73% (1.6 million), respectively, by 2040 on an annual basis.
Rising prevalence of cancer
One of the main uses of medical hyperspectral imaging is solid tumor detection. The non-invasive nature of cancer diagnosis, the omission of tissue biopsies, and the provision of diagnostic signatures without the requirement for a real-time contrast agent are some of the primary benefits linked to hyperspectral imaging. Furthermore, the market is growing as a result of the rising demand for medical hyperspectral imaging spurred on by the rising incidence of cancer.
Excessive cost of hyperspectral medical imaging systems
The price of the hyperspectral camera, light sources, software, reflectance panel, microscope, and additional accessories have been included in the cost of a hyperspectral imaging system. However, the expense of hyperspectral cameras and microscopes strains the healthcare system's ability to provide treatment within the allotted budget. For instance, hyperspectral cameras are produced by the Chinese business Optosky, and they cost between $45,000 and $48,800. This method frequently begins at USD 50,000 and rises upwards in the US.
Rising research to explore medical applications
As hyperspectral systems are still in their exploratory stages of usage in medicine, many studies are being conducted to diagnose diseases. A January 2023 NCBI research report states that hyperspectral imaging can be used to forecast the rate at which diabetic foot ulcers will heal. According to the study's results, hyperspectral imaging is an inexpensive test that can be readily included in regular clinical practice and may offer significant insights into DFU's capacity to heal.
Large-scale data storage
Due to the complexity of data, large storage areas are required, which limits market expansion and is not inexpensive for businesses. For instance, bulk data storage causes high space complexity for hyperspectral imaging systems combined with machine and deep learning, according to a Hindawi paper from April 2022. However, it takes a long time because of the massive amount of raw HSI data that needs to be tested and trained. This restricts market growth throughout the projection period.
The World Health Organization declared the disease a public health emergency in March 2020 after it spread to over 213 nations worldwide since the outbreak in December 2019. The COVID-19 pandemic resulted in a protracted lockdown in major nations such as the United States, China, Japan, India, and Germany, which led to the suspension of manufacturing facilities that do not correspond to critical products. It caused the majority of industrial facilities worldwide to either close or halt their production.
The cameras segment is expected to be the largest during the forecast period
Because imaging instruments are essential for improving therapeutic treatments and diagnostic accuracy, the cameras portion held the largest share. The wide range of wavelengths that hyperspectral cameras can record enables it feasible to analyze biological tissues in enormous detail and improve the detection of disorders. Additionally, the growing use of hyperspectral imaging for applications like real-time tissue distinction, illness detection, and surgical guidance is contributing to the demand increase. These cameras help with early detection and treatment planning by providing healthcare professionals with unique insights into tissue composition.
The ophthalmology segment is expected to have the highest CAGR during the forecast period
Because of the special powers of medical hyperspectral imaging to transform ocular diagnostics, the ophthalmology sector is predicted to grow profitably. Medical hyperspectral imaging in ophthalmology provides comprehensive insights into the retinal tissue, allowing for the accurate diagnosis of a variety of eye disorders, such as age-related macular degeneration and diabetic retinopathy. Moreover, the technology's capacity to extract spectral information from ocular tissues helps in the early diagnosis of abnormalities and offers useful information for customized therapies.
Owing to advancements in healthcare and growing technological usage, the Asia-Pacific region held the largest share. Modern medical imaging technologies are in high demand due to the region's expanding population and rising investments in healthcare infrastructure. The capacity of hyperspectral imaging to offer extensive spectral information for improved diagnosis of illnesses and surgical accuracy is in accordance with the region's increasing focus on cutting-edge medical technology. In addition, the prevalence of chronic illnesses like cancer and cardiovascular disorders has increased the demand for cutting-edge diagnostic tools, with hyperspectral imaging being offered as a revolutionary treatment.
Asia Pacific region is expected to hold lucrative growth due to government initiatives in nations like China, India, and Japan that support healthcare infrastructure and research abilities. Technological innovation is continuously driven in the region by a robust research community and collaborations between academic institutions and industry participants. Furthermore, widespread acceptance has been fueled by rising expertise among medical professionals of the benefits of hyperspectral imaging in a wide range of medical applications, such as ophthalmology, dermatology, and oncology.
Key players in the market
Some of the key players in Medical Hyperspectral Imaging market include Applied Spectral Imaging Inc, Bayspec Inc, Cubert GmbH, HyVista Corporation Pty Ltd, Inno-Spec GmbH, ITRES Research Limited, Norsk Elektro Optikk AS, Photonics Science Co, Resonon, Inc, Si-Ware Systems, Specim Spectral Imaging Ltd., Surface Optics Corporation and Tetracam Inc.
In July 2022, Headwall Photonics announced the acquisition of Holographix LLC to expand its manufacturing capabilities to address future growth.
In June 2022, Resonon Inc. announced the launch of Pika IR-L and IR-L+ hyperspectral cameras (925 - 1700 nm).